Literature DB >> 17286214

Evaluation of internal consistency and re-test reliability of Bath ankylosing spondylitis indices in a large cohort of adult and juvenile spondylitis patients in Taiwan.

James Cheng-Chung Wei1, Ruey-Hong Wong, Jun-Huang Huang, Chen-Tung Yu, Chung-Tei Chou, Ming-Shiou Jan, Gregory J Tsay, Ming-Chih Chou, Hong-Shen Lee.   

Abstract

The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Global Score (BAS-G) have been recommended for evaluating function and disability in patients with ankylosing spondylitis (AS). The aim of this study was to develop a Chinese version of the BASDAI, BASFI, and BAS-G and assess their reliability and validity. The Chinese version was obtained after a translation and back-translation process. A total of 447 patients with adult and juvenile AS were assessed using these three instruments. Reliability was tested by internal consistency and test-retest reliability. Internal consistency of the instrument was given as Cronbach's alpha. Test-retest reliability was assessed by intraclass correlation coefficient. To assess the sensitivity to change, 153 patients were included in an 8-week follow-up study. In our analysis, the reliability of these three instruments-the BASDAI, BASFI, and BAS-G-for a 24-h test-retest showed acceptable intraclass correlation coefficients (0.92-0.94). Our Chinese versions of the BASDAI, BASFI, and BAS-G also showed 0.87, 0.94, and 0.90, respectively, with Cronbach's alpha coefficient, indicating good reliability. For sensitivity to change in 8-week follow-up, all three instruments showed 5.0 to 5.4% changes. Our Chinese versions of the BASDAI, BASFI, and BAS-G showed adequate reliability, validity, and responsiveness to clinical change. Thus, disease activity and functional status in Chinese-speaking patients with AS may be adequately evaluated with these versions of the original instruments.

Entities:  

Mesh:

Year:  2007        PMID: 17286214     DOI: 10.1007/s10067-007-0573-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  31 in total

Review 1.  Plain radiographs as an outcome measure in ankylosing spondylitis.

Authors:  D van der Heijde; A Spoorenberg
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  The Swedish version of the Bath ankylosing spondylitis functional index. Reliability and validity.

Authors:  H Cronstedt; A Waldner; C H Stenström
Journal:  Scand J Rheumatol Suppl       Date:  1999

3.  Radiological manifestations of ankylosing spondylitis according to age at onset.

Authors:  M J Riley; B M Ansell; E G Bywaters
Journal:  Ann Rheum Dis       Date:  1971-03       Impact factor: 19.103

4.  The Bath Ankylosing Spondylitis Patient Global Score (BAS-G).

Authors:  S D Jones; A Steiner; S L Garrett; A Calin
Journal:  Br J Rheumatol       Date:  1996-01

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  A case-control study of juvenile- and adult-onset ankylosing spondylitis.

Authors:  S H Marks; M Barnett; A Calin
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

7.  Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondylarthropathy.

Authors:  S Heikkilä; J V Viitanen; H Kautianen; M Kauppi
Journal:  Clin Rheumatol       Date:  2000       Impact factor: 2.980

8.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors.

Authors:  S D Jones; W H Koh; A Steiner; S L Garrett; A Calin
Journal:  J Rheumatol       Date:  1996-03       Impact factor: 4.666

10.  Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies.

Authors:  M H Cardiel; J D Londoño; E Gutiérrez; C Pacheco-Tena; J Vázquez-Mellado; R Burgos-Vargas
Journal:  Clin Exp Rheumatol       Date:  2003 Jul-Aug       Impact factor: 4.473

View more
  18 in total

1.  Association of FCRL4 polymorphisms on disease susceptibility and severity of ankylosing spondylitis in Chinese Han population.

Authors:  Zhen Zeng; Zhenhua Duan; Tianchen Zhang; Sheng Wang; Guixing Li; Yang Mei; Jing Gao; Rui Ge; Dongqing Ye; Yanfeng Zou; Shengqian Xu; Jianhua Xu; Li Zhang; Faming Pan
Journal:  Clin Rheumatol       Date:  2012-07-10       Impact factor: 2.980

2.  Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?

Authors:  Yuen Ling Elaine Au; Woon Sing Raymond Wong; Mo Yin Mok; Ho Yin Chung; Eric Chan; Chak Sing Lau
Journal:  Clin Rheumatol       Date:  2014-07-01       Impact factor: 2.980

3.  Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis.

Authors:  Samira Rostom; Karima Benbouaaza; Bouchra Amine; Rachid Bahiri; Yousra Ibn Yacoub; Sanae Ali Ou Alla; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2010-04-10       Impact factor: 2.980

4.  Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis.

Authors:  Varun Dhir; Sujay Kulkarni; Ashish Adgaonkar; Poornima Dhobe; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2012-07-25       Impact factor: 2.980

5.  Functional limitation and associated factors in outpatients with ankylosing spondylitis in Southwest China.

Authors:  Yuqing Song; Chen Wang; Hong Chen
Journal:  Clin Rheumatol       Date:  2017-02-06       Impact factor: 2.980

6.  Cross-cultural adaptation and validation of the Chinese version of the Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S).

Authors:  DeLin Liu; Chen Zhang; Chen Wang; Jiao Liu; DaHe Li; Jia Li; Weidong Xu
Journal:  Clin Rheumatol       Date:  2017-07-27       Impact factor: 2.980

7.  Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients.

Authors:  Ole R Madsen; Anne Rytter; Lonnie B Hansen; Charlotte Suetta; Charlotte Egsmose
Journal:  Clin Rheumatol       Date:  2010-03-21       Impact factor: 2.980

8.  Associations of the PTPN22 and CTLA-4 genetic polymorphisms with Taiwanese ankylosing spondylitis.

Authors:  Chun-Huang Huang; James Cheng-Chung Wei; Chun-Chieh Chen; Chih-Shien Chuang; Chia-Hsuan Chou; Yu-Jie Lin; Ming-Fuu Wang; Ruey-Hong Wong
Journal:  Rheumatol Int       Date:  2013-11-09       Impact factor: 2.631

9.  Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis.

Authors:  Hyungpil Cho; Taikon Kim; Tae-Hwan Kim; Seunghun Lee; Kyu Hoon Lee
Journal:  Ann Rehabil Med       Date:  2013-10-29

10.  Association study of polymorphisms rs4552569 and rs17095830 and the risk of ankylosing spondylitis in a Taiwanese population.

Authors:  James Cheng-Chung Wei; Yu-Wen Hsu; Kuo-Sheng Hung; Ruey-Hong Wong; Chun-Huang Huang; Yi-Tzu Liu; Yuh-Cherng Guo; Shiro Ikegawa; Wei-Chiao Chang
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.